CD30-directed Immunoconjugate [EPC] - N0000182967
Pharmacologic Class Information
Pharmacologic Code | N0000182967 |
Pharmacologic Name | CD30-directed Immunoconjugate |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with CD30-directed Immunoconjugate
The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD30-directed Immunoconjugate [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
51144-050 | Adcetris | Non-Proprietary Name: Brentuximab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE |